ASPIRA SYNERGY
LIVE

Serial Number

90498294

Owner

Aspira Women's Health, Inc.

Attorney

Melissa Hunter-Ensor

Filing Date

Jan 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ASPIRA SYNERGY Trademark

Serial Number: 90498294 • Registration: 7219224

ASPIRA SYNERGY is a trademark filed by Aspira Women's Health, Inc. on January 29, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Aspira Women's Health, Inc.

12117 Bee Caves Road Building III,
Austin, TX 78738

Entity Type: 03

Trademark Details

Filing Date

January 29, 2021

Registration Date

November 14, 2023

Published for Opposition

October 25, 2022

Goods & Services

Providing on-line non-downloadable software for medical diagnostic testing in the fields of oncology, women's health, gynecology, ovarian cancer, breast cancer, endometriosis; Providing on-line non-downloadable software for gynecological diagnostic testing; Providing on-line non-downloadable software for cancer diagnostic testing; Software as a service (SAAS) services featuring software for medical diagnostic testing; Software as a service (SAAS) services featuring software for gynecological diagnostic testing; Software as a service (SAAS) services featuring software for cancer diagnostic testing; Software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; Providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing; Providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing; Providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 10, 2023 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Sep 11, 2023 SUPC
SOU EXTENSION 2 GRANTED
Sep 11, 2023 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 5, 2023 AITU
USE AMENDMENT FILED
Aug 28, 2023 IUAF
SOU EXTENSION 2 FILED
Aug 28, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 28, 2023 EEXT
TEAS STATEMENT OF USE RECEIVED
Aug 28, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 7, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 7, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 7, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2022 CNEA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 23, 2022 RCCK
CORRESPONDENCE E-MAILED
Feb 16, 2022 GRML
SUSPENSION LETTER WRITTEN
Feb 16, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 18, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 18, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2021 NWOS
NEW APPLICATION ENTERED
Feb 2, 2021 NWAP